Izee Medical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-10-2024
- Paid Up Capital ₹ 0.10 M
as on 29-10-2024
- Company Age 2 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.75 Cr
as on 29-10-2024
About Izee Medical Laboratories
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.75 Cr.
Aditya Talari and Jaya Talari serve as directors at the Company.
- CIN/LLPIN
U24100TG2022PTC168164
- Company No.
168164
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2022
- Date of AGM
13 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationSerilingampally, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Izee Medical Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Talari  | Director | 11-Nov-2022 | Current |
| Jaya Talari | Director | 11-Nov-2022 | Current |
Financial Performance of Izee Medical Laboratories.
Izee Medical Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Izee Medical Laboratories?
Unlock access to Izee Medical Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Trinaeni Constructions Private LimitedActive 2 years 5 months
Aditya Talari and Jaya Talari are mutual person
- 3-9E Innoworks Private LimitedActive 4 years 11 months
Aditya Talari and Jaya Talari are mutual person
Charges (Loans)
₹37.53 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 3.18 Cr
- Others : 0.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2024 | Others | ₹5.73 M | Open |
| 29 May 2023 | Canara Bank | ₹2.50 M | Open |
| 30 Nov 2022 | Canara Bank | ₹2.93 Cr | Open |
How Many Employees Work at Izee Medical Laboratories?
Unlock and access historical data on people associated with Izee Medical Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Izee Medical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Izee Medical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.